enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Epigallocatechin gallate - Wikipedia

   en.wikipedia.org/wiki/Epigallocatechin_gallate

   Epigallocatechin gallate (EGCG), also known as epigallocatechin-3-gallate, is the ester of epigallocatechin and gallic acid, and is a type of catechin. EGCG – the most abundant catechin in tea – is a polyphenol under basic research for its potential to affect human health and disease. EGCG is used in many dietary supplements.

3. Terns' oral weight-loss drug shows promise in early study ...

   www.aol.com/news/terns-pharmaceuticals-oral...

   (Reuters) -Terns Pharmaceuticals said its oral obesity drug reduced weight by an average of 4.9% in an early-stage study, joining drugmakers vying for a share of the lucrative weight-loss ...

4. 5 Best Weight Loss Supplements to Kickstart Your Health ... - AOL

   www.aol.com/entertainment/5-best-weight-loss...

   Green tea contains EGCG, an antioxidant that may contribute to fat oxidation, i.e., the body’s process of breaking down fat tissues. ... Some weight loss supplements and weight loss pills can ...

5. What are the best prescription weight loss pills? - AOL

   www.aol.com/best-prescription-weight-loss-pills...

   Weight loss drugs should be part of a comprehensive treatment plan that includes lifestyle modifications, like diet and exercise, counseling, and behavioral interventions. Adding lifestyle changes ...

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   Weight loss drugs have been developed since the early twentieth century, and many have been banned or withdrawn from the market due to adverse effects, including deaths; other drugs proved ineffective. Although many earlier drugs were stimulants such as amphetamines, in the early 2020s, GLP-1 receptor agonists became popular for weight loss.

7. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   Orlistat is used for the treatment of obesity.The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat.